
The Xanit Oncology Institute focuses on a very strong personalised patient care in its treatment of cancer.
Cancer treatment is generally lengthy and with our constant dedication and focus ensure access to and knowledge of the latest advances in a field of continuous development. Xanit Oncology offers maximum psychological support to patients paving the way towards a cure.
The Xanit Oncology Institute has the following units and treatments:
Carried out by means of a therapeutic plan set up by a multidisciplinary team, which includes staging, locoregional and systemic treatment, together with the follow up of solid tumours and lymphomas wherever their location.
The list of concrete and detailed services offered for every pathology is as follows:
General advice for the handling of side effects of chemotherapy for patients treated with chemotherapy in the Xanit Oncology Institute (IOX).
Other general advice:
General advice for the handling of side effects of chemotherapy for patients treated with chemotherapy in the Xanit Oncology Institute (IOX).
Chemotherapy is a treatment meant to destroy all cancer cells by means of pharmacological use. There are more than 50 different medical treatments to fight such pathology and to prevent malignous cells from growing, multiplying and be disseminated. Healthy cells usually grow and divide themselves in a controlled way meanwhile cancerous cells are mostly characterized by their out of control growth. Such pharmacological treatments are therefore used alone or in a combined way in order to stop such a chaotic multiplication.
The chemotherapeutical products can be used either orally (tablets, capsules or drinkable solution), but the digestive system does not always assimilate them which is why intramuscular injections or intra-venous ones can be necessary. The latter being the most frequent way since the oncologists can inject either in the patient’ hand or in his/her arm any of the treatments. Another option is the use of a catheter: flexible rubber tubing inserted in a major vein during the whole duration of the treatment. Sometimes, the catheter is connected to a device: a plastic or metal disc called port a catheter, inserted below the skin to avoid unnecessary extra punctures. In order to control the amount of medicine administrated an infusion pump fitted with a programmable piston operated therapeutic treatment delivery system is often used. When the treatment is an intramuscular one, the effects of chemotherapy do last longer since the absorbsion in muscular tissues is usually slowlier. Finally, in some cases, when the pathology has reached the spinal cord or the brain, it is necessary to administrate directly into the spinal fluid all medicines by means of the intra-spinal tunnelized catheters method which allows the chemotherapy to be injected directly into the intra-spinal space.
These are not the only ways of administration, others like creams or lotions applied directly on the skin, intra arterial treatments, and injections inside the very tumour… The doses and type of treatment varying according to the types of cancers and to the answer or personal situation of the patient and might be administrated daily or even weekly or monthly. The treatment is usually administrated on an alternative basis during cycles with some breaks in between for the body to start producing healthy cells again and recover itself from the medication effects. The cycles are a fundamental part for the chemotherapy treatment to be effective, which is why it is important to observe the hours and the rhythm, following the instructions given by the oncologists. The period of time elapsed between every cycle depends on the very treatment, though it usually last three to four weeks.
Some people can have the treatment at home, though others will need to have it in the consultation or in the day hospital fitted with beds where the patient only lies down during the treatment duration and then goes back home until the next session. It will occasionally be necessary for the patient to be taken as an in patient for the oncologists to observe the therapy effects and to adjust the doses on a more personalized basis. Some other medicine can produce interactions with chemotherapy which is why you shall need to ask your specialist before deciding taking any medicine or any tablet. Before taking laxatives, analgesic treatments, flu remedy, vitamins, herbal supplements…you shall need to ask your specialist about it.
The main difference between chemotherapy and other options offered to fight this pathology, -radiotherapy and surgery- is that it can be used in a systemic way. Which means these most particular treatments do not act in a determined area but do actually get to all body parts, where the malignous cells have extended themselves.
According to the type of cancer and to its staging, chemotherapy can be used to reach different goals:
The pharmacological treatment is usually completed with radiotherapy and sometimes including surgery. The neo adjuvant chemotherapy treatment is normally used to reduce the tumour size before it is excised; meanwhile, when therapy is used after the surgery to end up with all possible remnants of maglinous cells in the organism it is called adjuvant chemotherapy.
Every treatment is working according to different mechanisms, so that some can “poison” directly the malignous cells damaging their DNA while others are making the immune system react and be able to identify such cells as “foreign elements” and order their destruction. The activity or sleep of malignous cells depends sometimes on their reaction against hormones produced naturally by the body. In this particular case, the treatment is meant to erase the effects produced by the patient’s’ hormones.
The medicine agents used during oncology therapies can be divided into categories according to the way they work and according to how they affect malignous cells. If the specialists know the very moment of the cycle these products act and the concrete activity they really block to slow down the pathology extension, they will then be able to decide which treatment will have a more effective effect on every type of tumour, if they will need to combine various agents to get better results, if they can use these treatments together with others and including when to administrate them to get better results.
The three main differences between traditional chemotherapy and the new molecular treatments to fight cancer are:
The traditional way to find new pharmacological treatments against cancer has not usually been very sophisticated. Some "agent hunters" research teams do literally comb the earth to find new chemical agents. Any origin can be valid: tropical plants, minerals found in the deepest caves, deep sea animals…Most of these products are easily obtained and immediately thrown away; some because they are too difficult to get, others because they are easily oxidized, others because they cannot be mixed with water or because their components seem to be toxic. The remnant molecules characteristics are then tested to verify if they are anti cancerous. Laboratory rats used to be employed but nowadays malignous cells are cultivated in laboratories. Only a few agents between the thousands recollected do pass this testing part and become potential chemotherapy treatment candidates. Even thus, most of the latter will never become useful medicines.
While traditional agents against cancer have been “found”, new molecular treatments are "produced". What the research team is usually intending to find is the "molecular target" –a key asset during the whole process- against which the product will be proved to be effective. Cancer researchers do study first of all, how to build anew all the different stages between the normal cell and its transformation into the cancerous one, they then try to find some deficiencies, the Achiles’heel of such a process. It might be a substance most needed for cancerous cells to multiply themselves; or a protein acting as a go-between informing the DNA that a particular substance is present or not; or a gene that is "stuck" and working permanently when it only should work under specified circumstances; or a particular security system the tumoral cell has been able to bypass…
Once the target has been chosen and the action has been planned, the medicine is produced in the laboratory. When the weak point is for example a cell sensor which can "feel" the presence of all hormone-like material, we could design a molecule similar to that one and have it fixed onto the sensor to deactivate it; like a kind of "silicone injection into the door lock."
The traditional methods used to find anti-cancer agents are too rough, too gross. They are based upon quickly multiplying cell systems and are therefore unable to identify any other substance than the ones interfering with cell division. Accelerated cell division is truly an essential characteristic of cancer but it is certainly not the only one.